Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Investigating the malaria-driven autoimmune imprint of humoral immunity

Objective

Malaria was the strongest selective pressure in recent human evolution, yet its profound impact on our immune system is poorly understood. My recent work showed that high autoantibody (AAb) titers correlate with a 41% reduced risk of febrile malaria. These AAbs inhibit Plasmodium falciparum (Pf) growth and bind Pf invasion proteins. I propose that effective malaria immunity is autoreactive, presenting a paradigm shift where controlled breakdowns in immune tolerance are essential for protection. As tolerance mechanisms limit autoreactive immunity, this may explain the slow acquisition of natural immunity and poor malaria vaccine efficacy. It was suggested that genetic susceptibility to autoimmunity evolved as a survival advantage against malaria, and my data indicate the ability to develop an AAb response was central to this adaptation. Despite genetic susceptibility and elevated AAb titers, individuals in malaria-endemic regions are relatively protected from autoimmune diseases, likely due to an immune environment driven by chronic Pf malaria and other pathogens.
Foundational knowledge, which is now technically within reach, is required to exploit the connection between autoimmune disease and infection immunity, to improve malaria vaccines and transform autoimmune therapies. I propose comparative studies of autoreactive B cells and antibodies in autoimmune disease patients and malaria-exposed individuals, using field studies in Africa and advanced antigen-specific B cell methods, together with mouse models, to address the following key questions: 1) Do immune tolerance mechanisms impair malaria immunity? 2) What defines the immune environment of chronic Pf exposure that protects from autoimmune diseases?
This research will illuminate the genetic and individual imprint shaped by malaria, reveal barriers to effective malaria immunity and uncover immunoregulatory mechanisms in chronic malaria, potentially identifying therapeutic strategies for inflammatory conditions.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

HORIZON-ERC - HORIZON ERC Grants

See all projects funded under this funding scheme

Call for proposal

(opens in new window) ERC-2025-COG

See all projects funded under this call

Host institution

BERNHARD-NOCHT-INSTITUT FUER TROPENMEDIZIN
Net EU contribution
€ 1 960 433,00
Address
BERNHARD NOCHT STRASSE 74
20359 Hamburg
Germany
Region
Hamburg Hamburg Hamburg
Activity type
Research Organisations
Links
Total cost
€ 1 960 433,75

Beneficiaries (1)